These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 33713121)

  • 1. Letter to the editor: Colchicine and risk of non-cardiovascular death in patients with coronary artery disease: a pooled analysis underlying possible safety concerns.
    Fiolet ATL; Opstal TSJ; Mosterd A; Eikelboom JW; Nidorf SM; Thompson PL; Budgeon C; Tijssen JGP; Cornel JH
    Eur Heart J Cardiovasc Pharmacother; 2021 Jul; 7(4):e71. PubMed ID: 33713121
    [No Abstract]   [Full Text] [Related]  

  • 2. Response-letter to the editor: colchicine and risk of non-cardiovascular death in patients with coronary artery disease: a pooled analysis underlying possible safety concerns.
    Galli M; Princi G; Crea F; D'Amario D
    Eur Heart J Cardiovasc Pharmacother; 2021 Jul; 7(4):e72-e73. PubMed ID: 33725116
    [No Abstract]   [Full Text] [Related]  

  • 3. Colchicine and risk of non-cardiovascular death in patients with coronary artery disease: a pooled analysis underling possible safety concerns.
    Galli M; Princi G; Crea F; D'Amario D
    Eur Heart J Cardiovasc Pharmacother; 2021 May; 7(3):e18-e19. PubMed ID: 33270128
    [No Abstract]   [Full Text] [Related]  

  • 4. Colchicine for acute and chronic coronary syndromes.
    Imazio M; Andreis A; Brucato A; Adler Y; De Ferrari GM
    Heart; 2020 Oct; 106(20):1555-1560. PubMed ID: 32611559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colchicine in Stable Coronary Artery Disease.
    Fiolet ATL; Nidorf SM; Mosterd A; Cornel JH
    Clin Ther; 2019 Jan; 41(1):30-40. PubMed ID: 30396516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colchicine in Coronary Artery Disease: An Old Acquaintance in New Attire?
    Giannopoulos G; Angelidis C; Papoutsidakis N; Panagopoulou V; Cleman MW; Lekakis J; Deftereos S
    Curr Med Chem; 2015; 22(36):4177-88. PubMed ID: 26467282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose colchicine for coronary artery disease.
    Med Lett Drugs Ther; 2021 Apr; 63(1621):54-55. PubMed ID: 33830969
    [No Abstract]   [Full Text] [Related]  

  • 8. Colchicine in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis of Randomized Trials.
    Kofler T; Kurmann R; Lehnick D; Cioffi GM; Chandran S; Attinger-Toller A; Toggweiler S; Kobza R; Moccetti F; Cuculi F; Jolly SS; Bossard M
    J Am Heart Assoc; 2021 Aug; 10(16):e021198. PubMed ID: 34369166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comment on "Efficacy and safety of colchicine in patients with coronary artery disease: A systematic review and meta-analysis of randomized controlled trials".
    Liang H; Huang D
    Br J Clin Pharmacol; 2022 Jun; 88(6):3000-3001. PubMed ID: 35118689
    [No Abstract]   [Full Text] [Related]  

  • 10. Why Colchicine Should Be Considered for Secondary Prevention of Atherosclerosis: An Overview.
    Nidorf SM; Thompson PL
    Clin Ther; 2019 Jan; 41(1):41-48. PubMed ID: 30591286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colchicine and Acute Coronary Syndromes: A New Trick for an Old Drug?
    Amin G; Massoud G; Fares S; Booz GW; Zouein FA
    J Cardiovasc Pharmacol; 2022 Nov; 80(5):631-632. PubMed ID: 35998032
    [No Abstract]   [Full Text] [Related]  

  • 12. Colchicine for secondary prevention of cardiovascular disease.
    Nidorf SM; Eikelboom JW; Thompson PL
    Curr Atheroscler Rep; 2014 Mar; 16(3):391. PubMed ID: 24425060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colchicine in the Management of Acute and Chronic Coronary Artery Disease.
    Bouabdallaoui N; Tardif JC
    Curr Cardiol Rep; 2021 Jul; 23(9):120. PubMed ID: 34269908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colchicine Acutely Suppresses Local Cardiac Production of Inflammatory Cytokines in Patients With an Acute Coronary Syndrome.
    Martínez GJ; Robertson S; Barraclough J; Xia Q; Mallat Z; Bursill C; Celermajer DS; Patel S
    J Am Heart Assoc; 2015 Aug; 4(8):e002128. PubMed ID: 26304941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Colchicine in patients with coronary heart disease : LoDoCo2 trial].
    Koenig W; Nitschmann S
    Internist (Berl); 2021 Mar; 62(3):333-336. PubMed ID: 33580309
    [No Abstract]   [Full Text] [Related]  

  • 16. Colchicine may decrease cardiovascular events in patients with coronary artery disease.
    Griffin L; Groce J; Conway S
    J Fam Pract; 2022 Jul; 71(6):E1-E3. PubMed ID: 35994760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In patients with CAD, adding colchicine to evidence-based therapies reduces MACE without increasing adverse outcomes.
    Bates ER
    Ann Intern Med; 2021 Mar; 174(3):JC30. PubMed ID: 33646848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Colchicine in Coronary Artery Disease.
    Butt AK; Cave B; Maturana M; Towers WF; Khouzam RN
    Curr Probl Cardiol; 2021 Mar; 46(3):100690. PubMed ID: 32994053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colchicine for Secondary Cardiovascular Prevention: A Systematic Review.
    Webb CA; Barry AR
    Pharmacotherapy; 2020 Jun; 40(6):575-583. PubMed ID: 32259308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colchicine for Secondary Cardiovascular Prevention in Coronary Disease.
    Roubille F; Tardif JC
    Circulation; 2020 Nov; 142(20):1901-1904. PubMed ID: 33196312
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.